Editorial

You have full text access to this OnlineOpen article

Molecular ablation of transforming growth factor β signaling pathways by tyrosine kinase inhibition: The coming of a promising new era in the treatment of tissue fibrosis

  1. Joel Rosenbloom,
  2. Sergio A. Jiménez*

Article first published online: 30 JUL 2008

DOI: 10.1002/art.23634

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 58, Issue 8, pages 2219–2224, August 2008

Additional Information

How to Cite

Rosenbloom, J. and Jiménez, S. A. (2008), Molecular ablation of transforming growth factor β signaling pathways by tyrosine kinase inhibition: The coming of a promising new era in the treatment of tissue fibrosis. Arthritis & Rheumatism, 58: 2219–2224. doi: 10.1002/art.23634

Author Information

  1. Thomas Jefferson University, Philadelphia, Pennsylvania

*Jefferson Institute of Molecular Medicine, Thomas Jefferson University, 233 South 10th Street, Room 509 BLSB, Philadelphia, PA 19107-5541

Publication History

  1. Issue published online: 30 JUL 2008
  2. Article first published online: 30 JUL 2008
  3. Manuscript Accepted: 18 APR 2008
  4. Manuscript Received: 26 MAR 2008

Funded by

  • NIH. Grant Number: R01-AR-019616

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (201K)

First page of article

First page of Molecular ablation of transforming growth factor β signaling pathways by tyrosine kinase inhibition: The coming of a promising new era in the treatment of tissue fibrosis
View Full Article (HTML) Get PDF (201K)